Division of Critical Care, Department of Pediatrics, University of Ottawa, Children's Hospital of Eastern Ontario, 401 Smyth Road, Ottawa, ON, K1H 8L1, Canada.
Division of Emergency Medicine, Department of Pediatrics, University of Toronto, Hospital for Sick Children, Toronto, ON, Canada.
Syst Rev. 2019 Aug 5;8(1):195. doi: 10.1186/s13643-019-1109-2.
Isotonic crystalloid fluid bolus therapy is used in critically ill children to restore or maintain hemodynamic stability. However, the ideal choice of crystalloid remains to be determined. The most easily available and most frequently used crystalloid is 0.9% saline, an unbalanced crystalloid, that has been associated with hyperchloremic metabolic acidosis and acute kidney injury (AKI). Balanced fluids such as Ringer's lactate (RL) were developed to be closer to the composition of serum. However, they are more expensive and less readily available than 0.9% saline. Few trials have found RL to be associated with more favorable outcomes, but pediatric data is limited and inconsistent. The objective of the present systematic review is to review existing literature to determine the effect of balanced versus unbalanced fluid bolus therapy on metabolic acidosis in critically ill children.
Using the Preferred Reporting Items for Systematic Review and Meta-analysis Protocols (PRISMA-P) guidelines, we will conduct a systematic review to retrieve all controlled trials and observational studies comparing balanced and unbalanced resuscitative fluids in critically ill children from age 28 days to 18 years old in any resuscitation settings. Search strategy was developed in collaboration with an experienced clinical research librarian. The primary outcome is the incidence and/or time to resolution of metabolic acidosis. Secondary outcomes included the incidence of hyperchloremia, AKI, duration of renal replacement therapy, vasopressors, mechanical ventilation, total volume of rehydration needed per day, extracorporeal membrane oxygenation, and length of stay and mortality. Study screening, inclusion, data extraction, and assessment of risk of bias will be performed independently by two authors. We intend to perform a meta-analysis with studies that are compatible on the basis of population and outcomes.
Isotonic crystalloid fluid bolus therapy is a ubiquitous treatment in resuscitation of critically ill pediatric patients and yet there is no clear recommendation to support the choice of balanced versus unbalanced fluid. The present review will summarize current available data in the literature and assess whether recommendations can be generated regarding the choice of crystalloids or otherwise identify knowledge gaps which will open the door to a large-scale randomized controlled trial (RCT).
在危重病儿童中,使用等渗晶体液冲击疗法来恢复或维持血流动力学稳定。然而,理想的晶体选择仍有待确定。最容易获得和最常用的晶体是 0.9%生理盐水,这是一种不平衡的晶体,与高氯代谢性酸中毒和急性肾损伤 (AKI) 有关。平衡液,如乳酸林格氏液 (RL),被开发出来以更接近血清的成分。然而,它们比 0.9%生理盐水更昂贵且不易获得。很少有试验发现 RL 与更好的结果相关,但儿科数据有限且不一致。本系统评价的目的是回顾现有文献,以确定平衡与不平衡液体冲击疗法对危重病儿童代谢性酸中毒的影响。
使用系统评价和荟萃分析首选报告项目 (PRISMA-P) 指南,我们将进行系统评价,以检索所有比较平衡与不平衡复苏液在年龄 28 天至 18 岁的任何复苏环境中的危重病儿童的对照试验和观察性研究。检索策略是与一位经验丰富的临床研究图书馆员合作制定的。主要结局是代谢性酸中毒的发生率和/或缓解时间。次要结局包括高氯血症、AKI、肾脏替代治疗持续时间、血管加压素、机械通气、每天需要的补液总量、体外膜氧合和住院时间及死亡率。两名作者将独立进行研究筛选、纳入、数据提取和偏倚风险评估。我们打算根据人群和结局进行兼容性研究的荟萃分析。
等渗晶体液冲击疗法是复苏危重病儿童的普遍治疗方法,但目前尚无明确建议支持选择平衡与不平衡液体。本综述将总结目前文献中的现有数据,并评估是否可以提出关于晶体选择的建议,或者确定知识空白,这将为一项大规模随机对照试验 (RCT) 打开大门。